Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch a temporary demonstration program called the Medicare GLP-1 Bridge. The program is designed to provide eligible Medicare beneficiaries with access to certain GLP-1 medications used for weight management. The demonstration is currently scheduled to run through December 31, 2027.
What Is the Medicare GLP-1 Bridge?
The Medicare GLP-1 Bridge is a CMS demonstration program that operates separately from standard Medicare Part D prescription drug coverage. Eligible beneficiaries may have access to certain GLP-1 medications through a centralized CMS process rather than through their prescription drug plan’s normal coverage system.
According to CMS, the program is intended to provide access to certain GLP-1 medications while CMS gathers information about utilization and future coverage approaches.
Which Medications Are Included?
CMS currently lists the following medications as eligible under the demonstration when prescribed for weight management purposes:
- Wegovy® (injectable and tablet formulations)
- Zepbound® KwikPen®
- Foundayo®
Medication availability and eligibility requirements may change based on CMS guidance.
Who May Be Eligible?
Eligibility is determined by CMS requirements and a healthcare provider’s assessment.
In general, beneficiaries must:
- Be enrolled in Medicare Part D coverage through an eligible plan type
- Meet CMS clinical criteria
- Obtain required prior authorization
- Receive a prescription from a qualified healthcare provider for an approved weight-management indication
Not all Medicare beneficiaries will qualify, and eligibility is determined on an individual basis.
What Will the Cost Be?
CMS has announced that eligible beneficiaries may be able to access covered medications through the program for a $50 monthly copay. The program operates separately from standard Medicare Part D coverage, and these costs may not count toward normal Part D out-of-pocket spending calculations.
Important Things to Consider
GLP-1 medications are prescription drugs that may not be appropriate for everyone. Like any medication, they can have risks, side effects, and potential interactions with other medications.
Your healthcare provider can help determine whether a GLP-1 medication is appropriate based on your medical history, current medications, and health goals.
Talk With Your Doctor
If you are interested in learning whether you may qualify for the Medicare GLP-1 Bridge Program, the first step is to speak with your physician or healthcare provider. They can evaluate your individual situation and determine whether a GLP-1 medication may be appropriate for you.
If you have questions about your Medicare coverage, prescription drug plan options, or how Medicare works, the Kannonball Insurance Solutions team is available to help you understand your coverage choices.
Disclaimer
Kannonball Insurance Solutions does not determine eligibility for the Medicare GLP-1 Bridge Program. Eligibility, coverage, prior authorization requirements, and medication availability are determined by CMS and your healthcare provider. This article is for informational purposes only and is not medical advice. Always consult your physician regarding medical treatment decisions.
We do not offer every plan available in your area. We represent a number of MA organizations, which offer products in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program to get information on all of your options.